Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,140.00    -90.00 (-1.72%)
Bid:
5,135.00
Ask:
5,145.00
Spread: 10.00 (0.195%)
Market Cap: £3.74b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Trading Statement

9 May 2018 07:00

RNS Number : 4154N
Renishaw PLC
09 May 2018
 

Renishaw plc

Trading update

9th May 2018

Ahead of the investor day being held tomorrow, we are providing a trading update as follows:

 

Renishaw plc, the global high-precision metrology and healthcare technology group, publishes this trading update for the nine months ended 31st March 2018. It contains unaudited information that covers the first three quarters and the period since.

 

Trading activity

 

Continuing operations

9 months to 31st March 2018

9 months to 31st March 2017*

Change

Metrology

£406.6m

£361.4m

+12.5%

Healthcare

£23.3m

£22.9m

+1.7%

Total Revenue

£429.9m

£384.3m

+11.9%

 

 

 

 

Adjusted* Profit before tax

£97.6m

£70.1m

+39.2%

Statutory Profit before tax

£104.4m

£69.7m

+49.8%

 

 

Revenue from continuing operations for the first three quarters of the current financial year was £429.9m, an increase of 11.9% compared with £384.3m for the corresponding period last year. We experienced underlying growth at constant exchange rates of 16.4%, with growth in all regions.

 

In our metrology business revenue amounted to £406.6m compared with £361.4m for the same period last year, with an underlying growth at constant exchange rates of 16.9%. Revenue in our healthcare business was £23.3m compared with £22.9m for the same period last year, an increase of 5.9% at constant exchange rates.

 

Adjusted* profit before tax from continuing operations for the first three quarters amounted to £97.6m compared with a restated adjusted* profit before tax of £70.1m for the corresponding period last year.

 

Financial position 

The Group balance sheet remains strong with net cash balances of £91.2m as at 31st March 2018 (30th June 2017: £51.9m).

 

Outlook

Notwithstanding current economic uncertainties, the Board remains confident in the future prospects of the Group. In our half year interim report, we forecast full year revenue to be in the range of £575m to £605m and adjusted profit before tax to be in the range of £127m to £147m. We continue to expect growth in both revenue and profit for this financial year and now expect full year revenue to be in the range of £585m to £610m and adjusted profit before tax to be in the range of £135m to £150m. Statutory profit before tax is expected to be in the range of £145m to £160m.

The preliminary full year results for the year ending 30th June 2018 will be released on 26th July 2018.

 

 

Sir David McMurtry William Lee

CBE, RDI, FRS, FREng, CEng, FIMechE Chief Executive Officer

Executive Chairman

 

9th May 2018

 

 

 

Renishaw plc

Registered office New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number 1106260

LEI number 21380048ADXM6Z67CT18

Telephone number 01453 524524

Website www.renishaw.com 

 

 

* Adjusted profit before tax and prior year restatements

 

In the trading update issued on 10th May 2017, the cumulative profit before tax for the first three quarters of the financial year 2017 was reported as £69.3m. The results of the spatial measurement business have been excluded as this business has been reclassified as a discontinued activity, giving rise to an increase in profit before tax of £0.8m.

 

The adjustment to statutory profit relates to the accounting treatment of certain forward currency contracts used as hedging instruments which do not qualify for hedge accounting as they do not meet the hedge effectiveness criteria set out in the International Accounting Standard IAS39 'Financial Instruments: Recognition and Measurement'. The board deems that the adjusted profit before tax better reflects the underlying performance of the Group. The following table reconciles statutory profit before tax to adjusted profit before tax:

 

 

£'m

9 months to 31st March 2018

 

9 months to 31st March 2017

 

 

 

 

Profit before tax as previously reported

 

 

69.3

 

 

 

 

Restatement for discontinued operations

 

 

0.8

 

 

 

 

Restated adjusted profit before tax from continuing operations

97.6

 

70.1

 

 

 

 

Fair value gains/losses on financial instruments not eligible for hedge accounting

 

 

 

- reported in revenue

2.6

 

7.9

- reported in losses from the fair value of financial instruments

4.2

 

 (8.3)

 

 

 

 

Restated statutory profit before tax from continuing operations

104.4

 

69.7

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEASSPESAPEFF
Date   Source Headline
16th May 20239:45 amRNSAGM Voting Results Update Statement
9th May 20233:39 pmRNSNotice of Investor Day
28th Apr 20237:00 amRNSTrading Statement
2nd Feb 20237:00 amRNSHalf-year Report
24th Jan 20233:11 pmRNSNotice of Half-year Results
30th Nov 20224:38 pmRNSResult of AGM
31st Oct 20221:00 pmRNSNotice of AGM
28th Oct 20229:15 amRNSDirector/PDMR Shareholding
27th Oct 20227:00 amRNSTrading Statement
30th Sep 20227:00 amRNSAnnual Financial Report
29th Sep 202210:12 amRNSDirector/PDMR Shareholding
15th Sep 20227:00 amRNSFinal Results
6th Sep 20221:00 pmRNSNotice of Results
1st Jul 202212:31 pmRNSDirector Declaration
16th May 20225:56 pmRNSDirector/PDMR Shareholding
16th May 20227:00 amRNSAGM Voting Results Update Statement
10th May 20227:00 amRNSTrading Statement
12th Apr 202211:44 amRNSNotice of Investor Day
12th Apr 202210:58 amRNSDirector/PDMR Shareholding
31st Mar 20221:00 pmRNSDirectorate Change
18th Mar 20222:08 pmRNSHolding(s) in Company
14th Mar 20225:58 pmRNSDirector/PDMR Shareholding
1st Mar 20224:23 pmRNSDirectorate Change
3rd Feb 20227:00 amRNSHalf-year Report
17th Jan 20221:00 pmRNSNotice of Half-year Results
20th Dec 20214:05 pmRNSDirectorate Change
24th Nov 20213:57 pmRNSResult of AGM
29th Oct 20218:00 amRNSDirector/PDMR Shareholding
29th Oct 20217:00 amRNSAnnual Financial Report
21st Oct 202111:50 amRNSFinal Results Replacement
21st Oct 20217:00 amRNSFinal Results
21st Oct 20217:00 amRNSTrading Statement
27th Sep 202110:52 amRNSFinal Results Revised Date and Trading Update
17th Sep 202110:35 amRNSNotice of Results
31st Aug 202112:31 pmRNSHolding(s) in Company
3rd Aug 20213:05 pmRNSDirector/PDMR Shareholding
8th Jul 20213:20 pmRNSForm 8.3 - Renishaw plc
8th Jul 20217:00 amRNSForm 8.3
7th Jul 20213:20 pmRNSForm 8.3 - Renishaw plc
7th Jul 20213:13 pmRNSForm 8.3 - Renishaw plc
7th Jul 20212:26 pmEQSForm 8.3 - The Vanguard Group, Inc.: Renishaw plc
7th Jul 202111:48 amRNSForm 8.5 (EPT/NON-RI) - Renishaw plc
7th Jul 202111:14 amRNSForm 8.5 (EPT/RI) - Renishaw Plc
7th Jul 20217:00 amRNSUpdate on Formal Sale Process & Current Trading
6th Jul 20213:20 pmRNSForm 8.3 - Renishaw plc
6th Jul 20213:09 pmRNSForm 8.3 - Renishaw plc
6th Jul 20212:38 pmRNSForm 8.3 - Renishaw Plc
6th Jul 20212:13 pmRNSForm 8.3 - Renishaw Plc
6th Jul 20212:05 pmEQSForm 8.3 - The Vanguard Group, Inc.: Renishaw plc
6th Jul 202111:36 amRNSForm 8.5 (EPT/RI) - Renishaw Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.